课题基金 / 基金详情

Androgen Effects On Cognition In Turner Syndrome

Androgen Effects On Cognition In Turner Syndrome
雄激素对特纳综合征认知的影响
批准号:
6733493
负责人:
Judith L Ross
金额:
$29.05万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1994
资助国家:
美国
项目状态:
已结题
起止时间:
1994-01-01 至 2007-12-31

项目摘要

项目成果

Judith L Ross的其他基金

相似基金

相关文献

中文摘要
翻译
描述(申请人提供):雄激素是影响人类和动物大脑发育和行为的荷尔蒙。认知和行为的变化发生在青春期,同时女性和男性的性激素(雌激素和雄激素)水平显著增加。荷尔蒙的变化在模拟成人大脑成熟的最后阶段中扮演着重要的角色。患有特纳综合征(TS)的女孩丢失了全部或部分第二X染色体,出生时卵巢发育不良,因此在青春期前、青春期中和青春期后缺乏卵巢雌激素和雄激素。TS代表了一种独特的性激素缺乏模型,在该模型中研究雄激素治疗对女性认知和行为的生物学影响。这项正在进行的研究(NS32531)使用了1)两个TS组(开始时年龄为10-14岁),治疗四年:(A)雄激素治疗和(B)不使用雄激素(安慰剂)治疗,以及2)年龄匹配的正常女性对照组,也跟踪治疗四年。此外,所有TS女孩(两个治疗组)在研究的第三和第四年期间接受标准的雌激素替代治疗。我们建议继续并完成这项随机、双盲的临床试验。目前这项研究的延长标志着一个前所未有的机会,可以纵向监测四年雄激素治疗在青春期关键时期的影响。我们收集的数据表明,治疗的效果可能与组织因素有关,导致变化在较长一段时间内演变。目前尚不清楚观察到的增量变化是继续还是停滞不前。延长研究期限(四年),允许每个儿童完成四年的治疗,将有助于确定这一点。 本项目的具体目的是:1)检测雄激素治疗对生长激素治疗的TS女孩认知和心理调节的影响;2)记录青春期TS女孩(雄激素治疗前后)与年龄和VIQ匹配的正常女孩在认知和行为功能上的异同,并纵向跟踪4年。具体地说,我们假设:(1)接受雄激素治疗的TS女孩在涉及手的精细运动速度测试中的表现将比未接受雄激素治疗的TS女孩更好;(2)与未接受雄激素治疗的TS女孩相比,接受雄激素治疗的TS女孩在涉及精神转化的某些空间知觉测试中表现更快;(3)与未接受雄激素治疗的TS女孩相比,接受雄激素治疗的TS女孩在算术成绩测试中表现更好,这是一项学术成果;(4)接受雄激素治疗的TS女孩在语言测试中的表现相似。与未接受雄激素治疗的TS女孩相比,(5)接受雄激素治疗的TS受试者和对照组在空间知觉加工时间和算术学习成绩测试上的认知差异会随着时间的推移而减少,但不会消失,这表明TS的某些认知缺陷只是部分可逆的,以及(6)接受雄激素治疗的TS受试者和对照组在手精细运动速度测试上的差异将随着时间的推移而缩小和消失,表明TS中的某些认知缺陷是可逆的。 这项对青少年认知和社会发展的持续调查是理解正常大脑发育的重要一步。此外,这些数据将有助于确定如何优化特纳综合征的认知功能,并将扩大对男性/女性认知二态的机制的认识。
英文摘要
DESCRIPTION (provided by applicant): Androgens are hormones that influence brain development and behavior in humans and animals. Cognitive and behavioral changes occur during puberty, in concert with marked increases in sex hormone (estrogen and androgen) levels in females and males. Hormonal changes play a significant role in modeling the final stages of maturation in the adult brain. Girls with Turner syndrome (TS) are missing all or part of the second X chromosome, are born with dysgenetic ovaries, and therefore lack ovarian estrogen and androgen before, during, and after puberty. TS represents a unique, sex hormone-deficient model in which to study the biological effects of androgen treatment on cognition and behavior in females. The ongoing study (NS32531) utilizes 1) two TS groups (ages 10-14 years at start) treated for four years: (a) androgen-treated and (b) no androgen (placebo)-treated and 2) an age-matched, normal female control group, also followed for four years. Additionally, all TS girls (both treatment groups) receive standard estrogen replacement therapy during the 3rd and 4th years of the study. We propose to continue and complete this randomized, double-blind clinical trial. Extension of the current study marks an unprecedented opportunity to monitor longitudinally the influence of four years of androgen treatment across a critical period of adolescence. The data we have collected suggest that the effects of treatment may be related to organizational factors, resulting in changes that evolve over an extended period of time. It is unclear at present whether observed incremental changes continue or plateau. The extension (four years) of the study to permit each child to complete the four years of treatment will help to determine this. The specific aims of this project are to: 1) examine the effects of 4 years of androgen treatment on cognition and psychological adjustment in growth hormone-treated TS girls, 2) document the differences and similarities in cognitive and behavioral function between adolescent TS girls (treated or not treated with androgen) and age- and VIQ-matched normal girls, also followed longitudinally for 4 years. Specifically, we hypothesize that: (1) Girls with TS, treated with androgen, will perform better on tests of fine motor speed involving the hand, compared to girls with TS not treated with androgen, (2) Girls with TS, treated with androgen, will perform faster on certain tests of spatial perception, involving mental transformation, compared to girls with TS not treated with androgen, (3) Girls with TS, treated with androgen, will perform better on tests of arithmetic achievement, an academic outcome, compared to girls with TS not treated with androgen, (4) Girls with TS, treated with androgen, will perform similarly on tests of language, executive function, and attention, compared to girls with TS not treated with androgen, (5) The cognitive differences between androgen-treated TS subjects and controls on tests of spatial perceptual processing time and arithmetic academic performance will diminish but not disappear over time, indicating that certain cognitive deficiencies in TS are only partially reversible, and (6) The performance differences between androgen-treated TS subjects and controls on tests of fine motor speed of the hand will diminish over time and disappear, indicating that certain cognitive deficiencies in TS are reversible. This proposed continuing investigation of adolescent cognitive and social development represents an important step in understanding normal brain development. In addition, these data will help determine how to optimize cognitive function in Turner syndrome and will extend knowledge of the mechanisms of male/female cognitive dimorphisms.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The DE Nemours/duPont Hospital for Children IDeA States Pediatric Clinical Trials Network Site
The DE Nemours/duPont Hospital for Children IDeA States Pediatric Clinical Trials Network Site
DE PEDIATRIC COBRE: CLINICAL RESEARCH SERVICES CORE
Androgen effect on motor/cognitive outcome in Klinefelter syndrome
  • 批准号:
    7217906
  • 项目类别:
  • 资助金额:
    $56.38万
  • 财政年份:
    2006
  • 负责人:
    Judith L Ross
  • 依托单位:
海外基金